A systems biology approach to iron metabolism

Advances in Experimental Medicine and Biology

Volumn 844, Issue , 2014, Pages 201-225

  Chifman, Julia ^b   Laubenbacher, Reinhard ^a   Torti, Suzy V ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Constant decay rate; Continuous versus discrete models; Erythrocytes; Erythroid bone marrow; Heme; Homeostasis; Hydroxyl radical; Petri nets; Phagocytose; Phagocytosis; Plasma; Transferrin

Indexed keywords

(S) 2 HYDROXY ACID OXIDASE; ACONITATE HYDRATASE; ACONITATE HYDRATASE 2; BONE MORPHOGENETIC PROTEIN; CD71 ANTIGEN; CELL DIVISION CYCLE 14 HOMOLOG A; FERRITIN; FERROPORTIN; HEME OXYGENASE 1; HEMOJUVELIN; HEPCIDIN; HEPHAESTIN; HYDROXYACID OXIDASE 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IRON REGULATORY FACTOR; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MEMBRANE PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NEOGENIN; SIX TRANSMEMBRANE EPITHELIAL ANTIGEN OF THE PROSTATE; STAT3 PROTEIN; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER ZIP14; IRON;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ACERULOPLASMINEMIA; ANEMIA; ARTICLE; CHRONIC INFLAMMATION; COMPARTMENT MODEL; DNA SYNTHESIS; HEMOCHROMATOSIS; HEMOSIDEROSIS; HOMEOSTASIS; HUMAN; HYPOTRANSFERRINEMIA; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON HOMEOSTASIS; IRON METABOLISM; IRON METABOLISM DISORDER; IRON REFRACTORY IRON DEFICIENCY ANEMIA; IRON RESPONSIVE ELEMENT; IRON STORAGE; JUVENILE HEMOCHROMATOSIS; NEOPLASM; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; ANIMAL; BIOLOGICAL MODEL; DEFICIENCY; GENETICS; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; HOMEOSTASIS; HUMANS; IRON; IRON METABOLISM DISORDERS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; SYSTEMS BIOLOGY;

EID: 84916217513     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2095-2_10     Document Type: Article

References (93)

1. Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics. 2009;2:2
2. Hower V, et al. Ageneral map of iron metabolism and tissue-specific subnetworks. Mol Biosyst. 2009;5(5):422–43
3. Josephs HW. Absorption of iron as a problem in human physiology; a critical review. Blood. 1958;13(1):1–54
4. Laufberger V. Sur la cristallisation de la ferritine. Soc Chim Biol. 1937;19:1575–82
5. Feder JN, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13(4):399–408
6. Trowbridge IS, Omary MB. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci U S A. 1981;78(5):3039–43
7. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A. 1996;93(16):8175–82
8. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000;275(26):19906–12
9. Donovan A, et al. Positional cloning of zebrafish Fpn1 identifies a conserved vertebrate iron exporter. Nature. 2000;403(6771):776–81
10. Krause A, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480(2–3):147–50
11. McKie AT, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5(2):299–309
12. Park CH, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806–10
13. Pigeon C, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276(11):7811–9
14. Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112(2):219–30
15. Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69:69–85
16. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117(17):4425–33
17. Hentze MW, et al. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142 (1):24–38
18. Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr. 2008;28: 197–213
19. De Domenico I, Ward DM, Kaplan J. Hepcidin regulation: ironing out the details. J Clin Invest. 2007;117(7):1755–8
20. Gunshin H, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388(6641):482–8
21. Fleming MD, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997;16(4):383–6
22. Canonne-Hergaux F, et al. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood. 1999;93(12):4406–17
23. Oakhill JS, et al. Functional characterization of human duodenal cytochrome b (Cybrd1): redox properties in relation to iron and ascorbate metabolism. Biochim Biophys Acta. 2008;1777(3):260–8
24. Turi JL, et al. Duodenal cytochrome b: a novel ferrireductase in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;291(2):L272–80
25. Ferris CD, et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol. 1999;1(3):152–7
26. Arosio P, Levi S. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta. 2010;1800(8):783–92
27. Theil EC. Ferritin: at the crossroads of iron and oxygen metabolism. J Nutr. 2003; 133 (5 Suppl 1):1549S–53S.
28. Vulpe CD, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21(2):195–9
29. Schade AL, Caroline L. An Iron-binding component in human blood plasma. Science. 1946;104(2702):340–1
30. Ohgami RS, et al. The Steap proteins are metalloreductases. Blood. 2006;108(4):1388–94
31. Shaw GC, et al. Mitoferrin is essential for erythroid iron assimilation. Nature. 2006;440(7080):96–100
32. Krishnamurthy P, Xie T, Schuetz JD. The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther. 2007;114(3):345–58
33. Keel SB, et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science. 2008;319(5864):825–8
34. Donovan A, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005;1(3):191–200
35. Johnson MB, Enns CA. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood. 2004;104(13):4287–93
36. Kawabata H, et al. Molecular cloning of transferrin receptor 2.Anewmember of the transferrin receptor-like family. J Biol Chem. 1999;274(30):20826–32
37. Robb A, Wessling-Resnick M. Regulation of transferrin receptor 2 protein levels by transferrin. Blood. 2004;104(13):4294–9
38. Liuzzi JP, et al. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A. 2006;103(37):13612–7
39. Nemeth E, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090–3
40. De Domenico I, et al. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc Natl Acad Sci U S A. 2009;106(10):3800–5
41. Qiao B, et al. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab. 2012;15(6):918–24
42. Ross SL, et al. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab. 2012;15(6):905–17
43. Babitt JL, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38(5):531–9
44. Andriopoulos B Jr, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009;41(4):482–7
45. Meynard D, et al. Lack of the bone morphogenetic proteinBMP6induces massive iron overload. Nat Genet. 2009;41(4):478–81
46. Wang RH, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2005;2(6):399–409
47. Lee DH, et al. Neogenin inhibitsHJVsecretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood. 2010;115(15):3136–45
48. Zhang AS, et al. Hemojuvelin-neogenin interaction is required for bone morphogenic protein- 4-induced hepcidin expression. J Biol Chem. 2009;284(34):22580–9
49. Silvestri L, et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 2008;8(6):502–11
50. Gao J, et al. Interaction of the hereditary hemochromatosis proteinHFEwith transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 2009;9(3):217–27
51. Gao J, et al. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood. 2010;115(16):3374–81
52. Wallace DF, et al. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology. 2009;50(6):1992–2000
53. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108(9):3204–9
54. Pietrangelo A, et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology. 2007;132(1):294–300
55. Verga Falzacappa MV, et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007;109(1):353–8
56. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 2004; 113(9):1251–3
57. Shayeghi M, et al. Identification of an intestinal heme transporter. Cell. 2005;122(5):789–801
58. Qiu A, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006;127(5):917–28
59. Andrews NC. When is a heme transporter not a heme transporter? When it’s a folate transporter. Cell Metab. 2007;5(1):5–6
60. Rajagopal A, et al. Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature. 2008;453(7198):1127–31
61. Ferreira GC, Gong J. 5-Aminolevulinate synthase and the first step of heme biosynthesis. J Bioenerg Biomembr. 1995;27(2):151–9
62. Yoshida T, et al. Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem. 1988;171(3):457–61
63. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341(26):1986–95
64. Allen KJ, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358(3):221–30
65. Roetto A, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33(1):21–2
66. Papanikolaou G, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36(1):77–82
67. Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest. 2005;115(8):2180–6
68. Nemeth E, et al. Hepcidin is decreased inTFR2 hemochromatosis. Blood. 2005;105(4):1803–6
69. Sham RL, et al. Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326 S ferroportin mutation. Blood. 2009;114(2):493–4
70. Harris ZL, et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A. 1995;92(7):2539–43
71. Yoshida K, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet. 1995;9(3):267–72
72. Beutler E, et al. Molecular characterization of a case of atransferrinemia. Blood. 2000;96(13):4071–4
73. Nemeth E, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acutephase protein. Blood. 2003;101(7):2461–3
74. Nemeth E, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271–6
75. Torti SV, Torti FM. Ironing out cancer. Cancer Res. 2011;71(5):1511–4
76. Kotsopoulos J, et al. Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study. Cancer Causes Control. 2012;23(7):1065–74
77. Hann HW, Stahlhut MW, Blumberg BS. Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res. 1988;48(15):4168–70
78. Richardson DR. Iron chelators as therapeutic agents for the treatment of cancer. Crit Rev Oncol Hematol. 2002;42(3):267–81
79. Faulk WP, Hsi BL, Stevens PJ. Transferrin and transferrin receptors in carcinoma of the breast. Lancet. 1980;2(8191):390–2
80. Shan L, et al. Visualizing head and neck tumors in vivo using near-infrared fluorescent transferrin conjugate. Mol Imaging. 2008;7(1):42–9
81. Pinnix ZK, et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010;2(43):43–56
82. Miller LD, et al. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res. 2011;71(21):6728–37
83. Laubenbacher R, et al. A systems biology view of cancer. Biochim Biophys Acta. 2009;1796(2):129–39
84. Lao BJ, Kamei DT. A compartmental model of iron regulation in the mouse. J Theor Biol. 2006;243(4):542–54
85. Rivera S, et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106(6):2196–9
86. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117(3):285–97
87. Lopes TJ, et al. Systems analysis of iron metabolism: the network of iron pools and fluxes. BMC Syst Biol. 2010;4:112
88. Schumann K, et al. A method to assess 59Fe in residual tissue blood content in mice and its use to correct 59Fe-distribution kinetics accordingly. Toxicology. 2007;241(1–2):19–32
89. Chifman J, et al. The core control system of intracellular iron homeostasis: a mathematical model. J Theor Biol. 2012;300:91–9
90. Epsztejn S, et al. Fluorescence analysis of the labile iron pool of mammalian cells. Anal Biochem. 1997;248(1):31–40
91. Formanowicz D, et al. Petri net based model of the body iron homeostasis. J Biomed Inform. 2007;40(5):476–85
92. Formanowicz D, et al. Some aspects of the anemia of chronic disorders modeled and analyzed by petri net based approach. Bioprocess Biosyst Eng. 2011;34(5):581–95
93. Sackmann A, et al. An analysis of the petri net based model of the human body iron homeostasis process. Comput Biol Chem. 2007;31(1):1–10.